Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation

mBio

Volumn 6, Issue 5, 2015, Pages

  Gerstein, Aleeza C ^a,b,c   Fu, Man Shun ^a   Mukaremera, Liliane ^a   Li, Zhongming ^a   Ormerod, Kate L ^d   Fraser, James A ^d   Berman, Judith ^a,b,c   Nielsen, Kirsten ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ANEUPLOIDY; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DAUGHTER CELL; FEMALE; FUNGAL STRAIN; GENETIC VARIABILITY; HAPLOIDY; HOST PATHOGEN INTERACTION; IN VITRO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; POLYPLOIDY; PRIORITY JOURNAL; PROGENY; ANIMAL; ANTIFUNGAL RESISTANCE; C57BL MOUSE; CRYPTOCOCCOSIS; DISEASE MODEL; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANEUPLOIDY; ANIMALS; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HAPLOIDY; MICE, INBRED C57BL; MICROBIAL VIABILITY; POLYPLOIDY; STRESS, PHYSIOLOGICAL;

EID: 84946594483     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01340-15     Document Type: Article

References (61)

1. Idnurm A, Bahn Y, Nielsen K, Lin X, Fraser JA, Heitman J. 2005. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol 3:753-764. http://dx.doi.org/10.1038/nrmicro1245.
2. Hu G, Cheng P, Sham A, Perfect JR, Kronstad JW. 2008. Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol Microbiol 69:1456-1475. http://dx.doi.org/10.1111/j.1365-2958.2008.06374.x.
3. Crabtree JN, Okagaki LH, Wiesner DL, Strain AK, Nielsen JN, Nielsen K. 2012. Titan cell production enhances the virulence of Cryptococcus neoformans. Infect Immun 80:3776-3785. http://dx.doi.org/10.1128/IAI.00507-12.
4. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chrétien F, Heitman J, Dromer F, Nielsen K. 2010. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 6:e1000953. http://dx.doi.org/10.1371/journal.ppat.1000953.
5. Zaragoza O, Nielsen K. 2013. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol 16:409-413. http://dx.doi.org/10.1016/j.mib.2013.03.006.
6. Love GL, Boyd GD, Greer DL. 1985. Large Cryptococcus neoformans isolated from brain abscess. J Clin Microbiol 22:1068-1070.
7. Cruickshank JG, Cavill R, Jelbert M. 1973. Cryptococcus neoformans of unusual morphology. Appl Microbiol 25:309-312.
8. Wang JM, Zhou Q, Cai HR, Zhuang Y, Zhang YF, Xin XY, Meng FQ, Wang YP. 2014. Clinicopathological features of pulmonary cryptococcosis with cryptococcal titan cells: a comparative analysis of 27 cases. Int J Clin Exp Pathol 7:4837-4846.
9. Zaragoza O, García-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2010. Fungal cell gigantism during mammalian infection. PLoS Pathog 6:e1000945. http://dx.doi.org/10.1371/journal.ppat.1000945.
10. Wiesner DL, Specht CA, Lee CK, Smith KD, Mukaremera L, Lee ST, Lee CG, Elias JA, Nielsen JN, Boulware DR, Bohjanen PR, Jenkins MK, Levitz SM, Nielsen K. 2015. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog 11:e1004701. http://dx.doi.org/10.1371/journal.ppat.1004701.
11. Okagaki LH, Nielsen K. 2012. Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot Cell 11: 820-826. http://dx.doi.org/10.1128/EC.00121-12.
12. Okagaki LH, Wang Y, Ballou ER, O’Meara TR, Bahn Y-, Alspaugh JA, Xue C, Nielsen K. 2011. Cryptococcal titan cell formation is regulated by G-protein signaling in response to multiple stimuli. Eukaryot Cell 10: 1306-1316. http://dx.doi.org/10.1128/EC.05179-11.
13. Ezov TK, Boger-Nadjar E, Frenkel Z, Katsperovski I, Kemeny S, Nevo E, Korol A, Kashi Y. 2006. Molecular-genetic biodiversity in a natural population of the yeast Saccharomyces cerevisiae from “Evolution Canyon”: microsatellite polymorphism, ploidy and controversial sexual status. Genetics 174:1455-1468. http://dx.doi.org/10.1534/genetics.106.062745.
14. Abbey DA, Funt J, Lurie-Weinberger MN, Thompson DA, Regev A, Myers CL, Berman J. 2014. YMAP: a pipeline for visualization of copy number variation and loss of heterozygosity in eukaryotic pathogens. Genome Med 6:100. http://dx.doi.org/10.1186/PREACCEPT-1207699561372700.
15. Anderson CA, Roberts S, Zhang H, Kelly CM, Kendall A, Lee C, Gerstenberger J, Koenig AB, Kabeche R, Gladfelter AS. 2015. Ploidy variation in multinucleate cells changes under stress. Mol Biol Cell 26: 1129-1140. http://dx.doi.org/10.1091/mbc.E14-09-1375.
16. Otto SP, Whitton J. 2000. Polyploid incidence and evolution. Annu Rev Genet 34:401-437. http://dx.doi.org/10.1146/annurev.genet.34.1.401.
17. Otto SP, Gerstein AC. 2008. The evolution of haploidy and diploidy. Curr Biol 18:R1121-R1124. http://dx.doi.org/10.1016/j.cub.2008.09.039.
18. Cavalier-Smith T. 1978. Nuclear volume control by nucleoskeletal DNA, selection for cell volume and cell growth rate, and the solution of theDNA C-value paradox. J Cell Sci 34:247-278.
19. Pandit SK, Westendorp B, de Bruin A. 2013. Physiological significance of polyploidization in mammalian cells. Trends Cell Biol 23:556-566. http://dx.doi.org/10.1016/j.tcb.2013.06.002.
20. Lu P, Prost S, Caldwell H, Tugwood JD, Betton GR, Harrison DJ. 2007. Microarray analysis of gene expression of mouse hepatocytes of different ploidy. Mamm Genome 18:617-626. http://dx.doi.org/10.1007/s00335-007-9048-y.
21. Rancati G, Pavelka N, Fleharty B, Noll A, Trimble R, Walton K, Perera A, Staehling-Hampton K, Seidel CW, Li R. 2008. Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135:879-893. http://dx.doi.org/10.1016/j.cell.2008.09.039.
22. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequignot MO, Casares N, Valent A, Mouhamad S, Schmitt E, Modj-tahedi N, Vainchenker W, Zitvogel L, Lazar V, Garrido C, Kroemer G. 2006. Apoptosis regulation in tetraploid cancer cells. EMBO J 25: 2584-2595. http://dx.doi.org/10.1038/sj.emboj.7601127.
23. Galitski T, Saldanha AJ, Styles CA, Lander ES, Fink GR. 1999. Ploidy regulation of gene expression. Science 285:251-254. http://dx.doi.org/10.1126/science.285.5425.251.
24. Springer M, Weissman JS, Kirschner MW. 2010. A general lack of compensation for gene dosage in yeast. Mol Syst Biol 6:368. http://dx.doi.org/10.1038/msb.2010.19.
25. Inzé D, De Veylder L. 2006. Cell cycle regulation in plant development. Annu Rev Genet 40:77-105. http://dx.doi.org/10.1146/annurev.genet.40.110405.090431.
26. Storchova Z, Pellman D. 2004. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5:45-54. http://dx.doi.org/10.1038/nrm1276.
27. Song K, Lu P, Tang K, Osborn TC. 1995. Rapid genome change in synthetic polyploids of Brassica and its implications for polyploid evolution. Proc Natl Acad Sci U S A 92:7719-7723. http://dx.doi.org/10.1073/pnas.92.17.7719.
28. Mayer VW, Aguilera A. 1990. High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. Mutat Res 231:177-186. http://dx.doi.org/10.1016/0027-5107(90)90024-X.
29. Chen ZJ, Ni Z. 2006. Mechanisms of genomic rearrangements and gene expression changes in plant polyploids. Bioessays 28:240-252. http://dx.doi.org/10.1002/bies.20374.
30. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, Amon A. 2007. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317:916-924. http://dx.doi.org/10.1126/science.1142210.
31. Lv L, Zhang T, Yi Q, Huang Y, Wang Z, Hou H, Zhang H, Zheng W, Hao Q, Guo Z, Cooke HJ, Shi Q. 2012. Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells. Cell Cycle 11:2864-2875. http://dx.doi.org/10.4161/cc.21196.
32. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. 2005. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437:1043-1047. http://dx.doi.org/10.1038/nature04217.
33. Olaharski AJ, Sotelo R, Solorza-Luna G, Gonsebatt ME, Guzman P, Mohar A, Eastmond DA. 2006. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 27: 337-343. http://dx.doi.org/10.1093/carcin/bgi218.
34. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ. 1996. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett’s esophagus. Proc Natl Acad Sci U S A 93:7081-7084. http://dx.doi.org/10.1073/pnas.93.14.7081.
35. Siegel JJ, Amon A. 2012. New insights into the troubles of aneuploidy. Annu Rev Cell Dev Biol 28:189-214. http://dx.doi.org/10.1146/annurev-cellbio-101011-155807.
36. Duesberg P, Stindl R, Hehlmann R. 2001. Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy. Proc Natl Acad Sci U S A 98: 11283-11288. http://dx.doi.org/10.1073/pnas.201398998.
37. Lee AJX, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, Downward J, Szallasi Z, Tomlinson IPM, Howell M, Kschischo M, Swanton C. 2011. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res 71:1858-1870. http://dx.doi.org/10.1158/0008-5472.CAN-10-3604.
38. Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, Sanderson BW, Hattem GL, Li R. 2010. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 468: 321-325. http://dx.doi.org/10.1038/nature09529.
39. Selmecki A, Forche A, Berman J. 2006. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313:367-370. http://dx.doi.org/10.1126/science.1128242.
40. Selmecki A, Gerami-Nejad M, Paulson C, Forche A, Berman J. 2008. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol Microbiol 68:624-641. http://dx.doi.org/10.1111/j.1365-2958.2008.06176.x.
41. Pavelka N, Rancati G, Li R. 2010. Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr Opin Cell Biol 22:809-815. http://dx.doi.org/10.1016/j.ceb.2010.06.003.
42. Sionov E, Lee H, Chang YC, Kwon-Chung KJ. 2010. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 6:e1000848. http://dx.doi.org/10.1371/journal.ppat.1000848.
43. Sunshine AB, Payen C, Ong GT, Liachko I, Tan KM, Dunham MJ. 2015. The fitness consequences of aneuploidy are driven by conditiondependent gene effects. PLoS Biol 13:e1002155. http://dx.doi.org/10.1371/journal.pbio.1002155.
44. Ngamskulrungroj P, Chang Y, Hansen B, Bugge C, Fischer E, Kwon-Chung KJ. 2012. Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. PLoS One 7:e33022. http://dx.doi.org/10.1371/journal.pone.0033022.
45. Ormerod KL, Morrow CA, Chow EWL, Lee IR, Arras SDM, Schirra HJ, Cox GM, Fries BC, Fraser JA. 2013. Comparative genomics of serial isolates of Cryptococcus neoformans reveals gene associated with carbon utilization and virulence. G3 (Bethesda) 2013:113.005660v1. http://dx.doi.org/10.1534/g3.113.005660.
46. Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, Hebart H, Schumacher U, Einsele H. 1997. Resistance to fluconazole and crossresistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett 400:80-82. http://dx.doi.org/10.1016/S0014-5793(96)01360-9.
47. Selmecki AM, Dulmage K, Cowen LE, Anderson JB, Berman J. 2009. Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet 5:e1000705. http://dx.doi.org/10.1371/journal.pgen.1000705.
48. Desnos-Ollivier M, Patel S, Spaulding AR, Charlier C, Garcia-Hermoso D, Nielsen K, Dromer F. 2010. Mixed infections and in vivo evolution in the human fungal pathogen Cryptococcus neoformans. mBio 1:e00091-10. http://dx.doi.org/10.1128/mBio.00091-10.
49. Kronstad JW, Attarian R, Cadieux B, Choi J, D’Souza CA, Griffiths EJ, Geddes JMH, Hu G, Jung WH, Kretschmer M, Saikia S, Wang J. 2011. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 9:193-203. http://dx.doi.org/10.1038/nrmicro2522.
50. Joseph SB, Hall DW. 2004. Spontaneous mutations in diploid Saccharomyces cerevisiae: more beneficial than expected. Genetics 168:1817-1825. http://dx.doi.org/10.1534/genetics.104.033761.
51. Storchová Z, Breneman A, Cande J, Dunn J, Burbank K, O’Toole E, Pellman D. 2006. Genome-wide genetic analysis of polyploidy in yeast. Nature 443:541-547. http://dx.doi.org/10.1038/nature05178.
52. Harrison BD, Hashemi J, Bibi M, Pulver R, Bavli D, Nahmias Y, Wellington M, Sapiro G, Berman J. 2014. A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole. PLoS Biol 12:e1001815. http://dx.doi.org/10.1371/journal.pbio.1001815.
53. Chen G, Bradford WD, Seidel CW, Li R. 2012. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 482: 246-250. http://dx.doi.org/10.1038/nature10795.
54. Lengeler KB, Cox GM, Heitman J. 2001. Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infect Immun 69:115-122. http://dx.doi.org/10.1128/IAI.69.1.115-122.2001.
55. Sionov E, Chang YC, Kwon-Chung KJ. 2013. Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment. Antimicrob Agents Chemother 57:5127-5130. http://dx.doi.org/10.1128/AAC.00694-13.
56. Hu G, Wang J, Choi J, Jung W, Liu I, Litvintseva AP, Bicanic T, Aurora R, Mitchell TG, Perfect JR, Kronstad JW. 2011. Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients. BMC Genomics 12:526. http://dx.doi.org/10.1186/1471-2164-12-526.
57. García-Rodas R, Casadevall A, Rodríguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. 2011. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 6:e24485. http://dx.doi.org/10.1371/journal.pone.0024485.
58. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun 71:4831-4841. http://dx.doi.org/10.1128/IAI.71.9.4831-4841.2003.
59. Lengeler KB, Fox DS, Fraser JA, Allen A, Forrester K, Dietrich FS, Heitman J. 2002. Mating-type locus of Cryptococcus neoformans: a step in the evolution of sex chromosomes. Eukaryot Cell 1:704-718. http://dx.doi.org/10.1128/EC.1.5.704-718.2002.
60. Ni M, Feretzaki M, Li W, Floyd-Averette A, Mieczkowski P, Dietrich FS, Heitman J. 2013. Unisexual and heterosexual meiotic reproduction generate aneuploidy and phenotypic diversity de novo in the yeast Cryptococcus neoformans. PLoS Biol 11:e1001653. http://dx.doi.org/10.1371/journal.pbio.1001653.
61. Velegraki A, Kambouris M, Kostourou A, Chalevelakis G, Legakis NJ. 1999. Rapid extraction of fungal DNA from clinical samples for PCR amplification. Med Mycol 37:69-73. http://dx.doi.org/10.1080/02681219980000101.